Clinical Trial Update: Treatment of Systemic Sclerosis With Autologous Regulatory Т-cells [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update investigating autologous regulatory T-cells for systemic sclerosis in Phase 1 and Phase 2, with unknown current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• autologous regulatory T-cells (regulatory T-cells)

Snippet

Sponsor: Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Conditions: Systemic Sclerosis | Phase 1, Phase 2 | Status: UNKNOWN